Dissecting the role of IKK-epsilon in tick immunity and vector competence

Active Project Grant Awarded Last action

Award ID
F32AI202938
Recipient
Awarding agency
Obligated
$76,780

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 0% complete
Place of performance
Pullman, WA 99164, USA

Award details come from USAspending.gov.

Description

Abstract
Tick species such as ixodes scapularis are major vectors of bacterial pathogens, including lyme disease and granulocytic anaplasmosis. Nevertheless, strategies for controlling tick-borne disease are extremely limited and do not address vector competence, or the ability for ticks to harbor and transmit these pathogens. One major factor controlling vector competence is the tick immune response to infection, of which mechanistic knowledge is profoundly lacking. To develop effective, targeted methods to prevent tick-borne disease before patients become sick, a far greater understanding of tick immune pathways is necessary. We recently discovered that the non-canonical IΚB kinase ikkε restricts tick bacterial burden by stimulating the IMD pathway, a vital arthropod innate immune response orthologous to mammalian tnfr-NF-ΚB signaling. Furthermore, phosphoproteomic analysis indicates that ikkε regulates numerous signaling pathways relevant to tick immunity. The central hypothesis of this study is that tick ikkε functions as a central point of immune regulation, interacting with multiple signaling networks, including the IMD pathway, which impact vector competence. Preliminary data indicate that ikkε phosphorylates the IMD pathway core regulator xiap. In aim 1, IMD-activating interactions between ikkε and xiap will be characterized by performing molecular and biochemical interaction assays and by applying CAS9-mediated gene editing and targeted mutagenesis techniques. In aim 2, the tick ikkε signaling network will be mapped through complementary unbiased methods including proximity-based protein labeling, proteomics, and transcriptomics. Many tick orthologs of canonical phosphorylation targets of ikkε are lacking conserved motifs, rendering the mechanisms of ikkε immune induction unclear. These screens will reveal molecular targets which ikkε signals through to restrict tick pathogen burden. The results of this study will lead to new avenues of investigation for targeted control of tick-borne disease at the vector level. This project is conducted at washington state university, which has long-standing prominence in the field of tick-borne disease and whose investigators foster a highly collaborative research community. The training plan associated with this project is facilitated by the joint mentorship of DR. Dana shaw (primary sponsor) and DR. Erol fikrig (CO-sponsor). At the conclusion of this fellowship, DR. Osbron will transition into a position as an independent investigator.

Quick answers

Who received award F32AI202938?

F32AI202938 was awarded to Washington State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 29, 2027.

How much is award F32AI202938 worth?

$76,780 has been obligated on F32AI202938.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award